Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants
Abstract As part of a multicenter study evaluating homologous and heterologous COVID-19 booster vaccines, we assessed the magnitude, breadth, and short-term durability of binding and pseudovirus-neutralizing antibody (PsVNA) responses following a single booster dose of NVX-CoV2373 in adults primed w...
Full description
Bibliographic Details
| Main Authors: |
Kirsten E. Lyke,
Robert L. Atmar,
Clara Dominguez Islas,
Christine M. Posavad,
Meagan E. Deming,
Angela R. Branche,
Christine Johnston,
Hana M. El Sahly,
Srilatha Edupuganti,
Mark J. Mulligan,
Lisa A. Jackson,
Richard E. Rupp,
Christina A. Rostad,
Rhea N. Coler,
Martín Bäcker,
Angelica C. Kottkamp,
Tara M. Babu,
David Dobrzynski,
Judith M. Martin,
Rebecca C. Brady,
Robert W. Frenck,
Kumaravel Rajakumar,
Karen Kotloff,
Nadine Rouphael,
Daniel Szydlo,
Rahul PaulChoudhury,
Janet I. Archer,
Sonja Crandon,
Brian Ingersoll,
Amanda Eaton,
Elizabeth R. Brown,
M. Juliana McElrath,
Kathleen M. Neuzil,
David S. Stephens,
Diane J. Post,
Bob C. Lin,
Leonid Serebryannyy,
John H. Beigel,
David C. Montefiori,
Paul C. Roberts,
the DMID 21-0012 Study Group |
|---|
| Format: | Article
|
|---|
| Language: | English |
|---|
| Published: |
Nature Portfolio
2023-07-01
|
|---|
| Series: | npj Vaccines
|
|---|
| Online Access: | https://doi.org/10.1038/s41541-023-00693-z
|
|---|